MRI of the Brain and Spine: What It Reveals

Magnetic resonance imaging of the brain and spine is one of the most diagnostically powerful tools in clinical neurology, capable of detecting structural, vascular, and inflammatory changes that other imaging modalities cannot resolve. This page covers how MRI works in a neurological context, the specific conditions it identifies, the technical variants used in practice, and the clinical boundaries that determine when MRI is appropriate versus when alternative imaging is preferred. Understanding what MRI can and cannot reveal helps clarify the diagnostic process for patients and clinicians alike.

Definition and scope

MRI of the brain and spine uses powerful magnetic fields and radiofrequency pulses to generate detailed cross-sectional images of soft tissue, including the brain parenchyma, white matter tracts, cranial nerves, spinal cord, intervertebral discs, and surrounding cerebrospinal fluid spaces. Unlike computed tomography, MRI does not use ionizing radiation. This distinction is clinically significant: the FDA's Center for Devices and Radiological Health classifies MRI as a non-ionizing imaging modality, which affects its risk profile in vulnerable populations including children and pregnant patients.

The scope of neurological MRI spans two primary anatomical domains:

Both domains inform the full picture of nervous system disease covered across the neurological conditions and diagnostic landscape. For broader context on how imaging fits within regulatory and clinical practice standards, the regulatory context for neurological practice outlines the governing frameworks that apply to diagnostic procedures in the United States.

How it works

Clinical MRI systems used in neurology typically operate at field strengths of 1.5 Tesla or 3 Tesla. Higher field strength yields higher signal-to-noise ratio and improved spatial resolution — 3T scanners can resolve structural detail at sub-millimeter precision in research-grade protocols (according to published imaging physics literature from the American College of Radiology).

The imaging process relies on the behavior of hydrogen protons in biological tissue when exposed to a magnetic field. Protons align with the field, then absorb energy from radiofrequency pulses, and emit signals as they return to equilibrium. Different tissue types — gray matter, white matter, cerebrospinal fluid, fat, and pathological tissue — emit distinct signal patterns. These differences are captured as contrast variations across pulse sequences.

Key pulse sequences in neurological MRI

  1. T1-weighted imaging: Best for anatomical detail; gadolinium-based contrast agents enhance breakdown of the blood-brain barrier, appearing bright on T1 post-contrast sequences. Used to detect tumors, abscesses, and active inflammation.
  2. T2-weighted imaging: Fluid and edema appear hyperintense (bright); useful for detecting demyelinating lesions, infarction, and syrinx in the spinal cord.
  3. FLAIR (Fluid-Attenuated Inversion Recovery): Suppresses CSF signal, making periventricular white matter lesions more visible — critical in multiple sclerosis diagnosis per McDonald Criteria.
  4. Diffusion-Weighted Imaging (DWI): Detects restricted water diffusion within minutes of acute ischemic stroke; the sensitivity of DWI for acute infarct exceeds 80% within the first few hours of symptom onset (American Heart Association/American Stroke Association 2019 Acute Ischemic Stroke Guidelines).
  5. Gradient Echo / Susceptibility-Weighted Imaging (SWI): Identifies microhemorrhages, cavernous malformations, and hemosiderin deposits.
  6. MR Angiography (MRA): Visualizes intracranial and cervical arteries without arterial catheterization; used to screen for aneurysms and arteriovenous malformations.
  7. MR Spectroscopy: Measures metabolite concentrations in brain tissue; helps differentiate tumor recurrence from radiation necrosis.

Gadolinium contrast agents used in MRI carry their own safety classification. The FDA issued guidance updates on gadolinium retention in 2017, noting that linear agents deposit in brain tissue at higher rates than macrocyclic agents (FDA Drug Safety Communication, 2017).

Common scenarios

Neurological MRI is ordered across a broad range of clinical presentations. The following categories represent the conditions most commonly evaluated through brain and spinal MRI in clinical practice:

Stroke and vascular disease: DWI sequences detect acute ischemic infarcts within 30 minutes of onset in the majority of cases. MRA identifies large vessel occlusion, carotid stenosis, and intracranial aneurysm. The stroke-treatment pathway depends heavily on MRI findings in centers that use MR-based perfusion imaging.

Demyelinating disease: Multiple sclerosis diagnosis under 2017 McDonald Criteria requires demonstration of lesions disseminated in space and time on MRI. Typical MS lesions are ovoid, periventricular, and hyperintense on T2/FLAIR. Spinal cord lesions, when present, are typically less than 2 vertebral segments in length — a feature that distinguishes MS from neuromyelitis optica spectrum disorder (NMOSD), where lesions frequently extend 3 or more vertebral segments (Wingerchuk criteria, Mayo Clinic Proceedings).

Epilepsy: Structural MRI at 3T can identify hippocampal sclerosis, focal cortical dysplasia, and low-grade tumors in patients with drug-resistant epilepsy. The surgical treatment for epilepsy pathway requires high-resolution MRI as a prerequisite for surgical candidacy evaluation.

Brain tumors: MRI with and without gadolinium contrast is the standard imaging modality for characterizing intracranial masses, evaluating for leptomeningeal spread, and monitoring treatment response. The World Health Organization's 2021 CNS Tumor Classification integrates MRI findings with molecular markers (WHO Classification of Tumors of the Central Nervous System, 5th Edition).

Spinal cord disorders: Compressive myelopathy from disc herniation or spondylosis is characterized by cord signal change on T2 at the level of compression. Transverse myelitis produces longitudinal cord hyperintensity. Peripheral neuropathy and radiculopathy evaluations frequently begin with lumbar MRI to distinguish spinal from peripheral causes.

Traumatic brain injury: SWI sequences detect diffuse axonal injury through microhemorrhage patterns invisible on CT. MRI is preferred over CT for subacute and chronic TBI assessment despite CT remaining the first-line acute tool.

Headache and migraine: MRI is used to exclude secondary causes in patients with persistent headaches and warning signs, including new-onset headache after age 50, thunderclap presentation, or headache with neurological deficits.

Decision boundaries

MRI is not universally the first-choice imaging modality across all neurological presentations. Clinical decision-making depends on the acuity of the presentation, the diagnostic question, contraindications, and resource availability.

MRI vs. CT: CT is faster, more widely available, and does not require patient cooperation over an extended period — making it the standard first-line tool in acute stroke triage (to exclude hemorrhage) and head trauma. MRI surpasses CT in sensitivity for posterior fossa lesions, white matter pathology, early infarction, and spinal cord evaluation. CT provides superior detail of cortical bone, making it preferred for skull fracture assessment.

Contraindications: The ACR's Manual on MR Safety identifies absolute contraindications including certain cardiac pacemakers, cochlear implants, and ferromagnetic foreign bodies in critical locations. Many modern implanted devices, including select deep brain stimulators and cardiac devices, carry conditional MRI labeling subject to specific field strength and SAR (specific absorption rate) limits. The deep brain stimulation procedure introduces MRI safety complexity that requires device-specific protocols.

Gadolinium considerations: Gadolinium contrast is withheld or used with caution in patients with an estimated glomerular filtration rate below 30 mL/min/1.73m² due to risk of nephrogenic systemic fibrosis, as classified by the ACR's contrast manual (ACR Manual on Contrast Media, 2023 edition).

When MRI may be insufficient: Functional neurological evaluation, cortical activity mapping, and electrodiagnostic assessment of peripheral nerves and neuromuscular junctions require modalities distinct from structural MRI — including EEG, EMG and nerve conduction studies, and evoked potentials. Cerebral angiography remains the gold standard for detailed vascular mapping when MRA resolution is inadequate.

Pediatric and pregnancy considerations: MRI

The law belongs to the people. Georgia v. Public.Resource.Org, 590 U.S. (2020)